Types I and III procollagen extension peptides in serum respond to fracture in humans

Arch Orthop Trauma Surg. 1992;111(5):265-7. doi: 10.1007/BF00571521.

Abstract

Markers of types I and III collagen turnover were measured in serial blood samples in 16 patients with a Colles' fracture. The collagen markers were the carboxy-terminal extension peptide of type I procollagen (PICP) and the amino-terminal extension peptide of type III procollagen (PIIINP). Significant increases were found of PIIINP within 1 week and of PICP within 2 weeks. This sequential appearance of PIIINP and PICP was found to be in agreement with the appearance of types III and I collagen during early fracture healing as demonstrated in previous animal experimental studies. PICP had levelled off after 9 months, whereas PIIINP remained elevated. Osteocalcin, a serum marker of osteoblast activity, increased within 1 week and levelled off after 9 months. Correlations between the change in osteocalcin and those in PICP and PIIINP, respectively, were weak. These new biochemical markers may prove relevant as non-invasive markers of normal and pathological fracture healing in humans.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Colles' Fracture / blood*
  • Colles' Fracture / therapy
  • Female
  • Humans
  • Male
  • Middle Aged
  • Osteocalcin / blood
  • Peptide Fragments / blood*
  • Procollagen / blood*

Substances

  • Peptide Fragments
  • Procollagen
  • procollagen Type III-N-terminal peptide
  • procollagen type I carboxy terminal peptide
  • Osteocalcin